In prostate cancer, PET tracers targeting prostate-specific membrane antigen (PSMA) have demonstrated high diagnostic accuracy for the detection of both regional and distant metastatic prostate cancer [3, 4]. The gene discussed is FOLH1; the disease is prostate cancer.